Brief: Medite Cancer Diagnostics Q2 loss per share $0.06

Medite Cancer Diagnostics

14/08/2017 22:00

Aug 14 (Reuters) - Medite Cancer Diagnostics Inc  MDIT.PK : 
    * Medite Cancer Diagnostics reports 2017 second quarter and 
first six month financial results 
    * Q2 loss per share $0.06 
 
Source text for Eikon:  ID:nMKWWR8GJa  
Further company coverage:  MDIT.PK  
 
 ((Bangalore.newsroom@thomsonreuters.com;))